Search AMS
AMERICAN SHARED HOSPITAL SERVICES
NYSE · CIK 744825
Last close1.41
Daily change-0.02 (-1.40%)
10 Years gain-54.95%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
AMS · STANDARD
SIC 8071 · Services-Medical Laboratories · Fiscal year end 1231
Fundamental
20.5Momentum
73.0Acceleration
72.3Confidence
83.0Annual Revenue17
Quarterly Revenue56
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth5.5 / 25
Quality4.7 / 25
Capital Efficiency2.0 / 20
Balance Sheet2.3 / 15
Shareholder Economics5.0 / 10
Forward Indicators0.0 / 5
Signals
Operating leverageOperating margin improved by 4.599 percentage points.
ROIC expansionROIC improved by 4.2641 percentage points.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 7.3565 percentage points.
Low interest coverage · HIGHInterest coverage is -1.9129x.
Key Metrics
Revenue Growth TTM1.78%OK
Revenue CAGR 3Y12.46%OK
Gross Margin19.95%OK
Operating Margin-9.15%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-6.5%OK
Incremental Operating Margin 3Y-46.83%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y4.56%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $28.08M | $5.06M | -$3.59M | $3.10M | -$4.54M | 18.03% | -12.78% | -16.15% | -7.81% | 6.62M |
| 2025 FY Dec 31, 2024 | $28.34M | $9.19M | -$2.81M | $167,000.00 | -$7.77M | 32.41% | -9.9% | -27.42% | -7.52% | 6.7M |
| 2024 FY Dec 31, 2023 | $21.33M | $9.34M | $270,000.00 | $5.72M | -$555,000.00 | 43.82% | 1.27% | -2.6% | 0.78% | 6.39M |
| 2023 FY Dec 31, 2022 | $19.75M | $8.38M | $2.43M | $7.24M | $6.85M | 42.45% | 12.31% | 34.68% | 6.27% | 6.3M |
| 2022 FY Dec 31, 2021 | $17.63M | $6.73M | $1.35M | $6.27M | $4.59M | 38.16% | 7.66% | 26.06% | 4.08% | 6.06M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $29.76M | sum latest 4 fiscal quarters Revenue | OK | 0001437749-26-027716, 0001437749-26-001452 |
| Revenue Growth TTM | 1.78% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001437749-26-027716, 0001437749-26-001452 |
| Revenue CAGR 3Y | 12.46% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001437749-26-010731 |
| Revenue CAGR 5Y | 9.5% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001437749-26-010731 |
| Gross Profit CAGR 3Y | -15.46% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001437749-26-010731 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001437749-26-027716, 0001437749-26-001452 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 19.95% | Gross Profit / Revenue | OK | 0001437749-26-027716, 0001437749-26-001452 |
| Operating Margin | -9.15% | Operating Income / Revenue | OK | 0001437749-26-027716, 0001437749-26-001452 |
| ROIC | -6.5% | NOPAT / Average Invested Capital | OK | 0001437749-26-027716, 0001437749-26-001452 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001437749-26-027716 |
| Interest Coverage | -1.91x | Operating Income / abs(Interest Expense) | OK | derived |
| Current Ratio | 0.77x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.4x | (Cash + Short-term Investments) / Total Debt | OK | 0001437749-26-027716 |